Investing Profile

Laura Stoppel

InvestorVC
Partner at RA Capital Management
racap.comSomerville, Massachusetts
Photo of Laura Stoppel, Partner at RA Capital Management
Your Intro Paths to Laura Stoppel

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Laura is a member of
Harvard University Network
598 CONNECTIONS
Massachusetts Institute of Technology Network
392 CONNECTIONS
RA Capital Management Network
35 CONNECTIONS
RA Capital Management Network
35 CONNECTIONS
RA Capital Management Network
35 CONNECTIONS

Find Laura Stoppel on

cb
Current Investing Position
RA Capital Management Partner
Investment Range
$100K - $5.0M
Sweet Spot
$100K
Investments On Record
12
Current Fund Size
$308.2M

Laura Stoppel is on these Sector & Stage Rankings

Laura Stoppel's Investments On Record (6)

CompanyStageDateRound SizeTotal Raised
Contraline
Series BJun 2026$93M
$120M
Co-investors: Jason Calacanis (Sequoia Capital), Gurdane Bhutani (MBX Capital), Ramtin Naimi (Abstract Ventures), Cyan Banister (Long Journey Ventures), Jaffray Woodriff, Bill Smith
CellCentric
Series DMay 2026$220M
Series CMay 2025$120M
Series UnknownJul 2024$35M
$380M
Co-investors: Jasper Bos (Forbion)
Gameto
Series CAug 2025$44M
Series BMay 2024$33M
$120M
Co-investors: Dan Rose (Coatue), Dylan Morris (Insight Partners), Peter Kolchinsky (RA Capital), Steve Jurvetson (Baruch Future Ventures), Anne Wojcicki (23andMe), Maryanna Saenko (Baruch Future Ventures), Robert Nelsen (ARCH Venture Partners), Viktoriya Tigipko (TA Ventures), Jack Abraham (Atomico), Dusan Perovic (Two Sigma Ventures), Kristina Simmons (Overwater Ventures)
Nimbus Therapeutics
Series UnknownSep 2022$130M
Series UnknownJul 2021$110M
Series UnknownOct 2020$60M
$640M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Bruce Booth (Atlas Venture), Vicki Sato (ARCH Venture Partners), Rajeev Dadoo (SR One), Peter Kolchinsky (RA Capital), Nikola Trbovic (Pfizer Venture Investments), Bill Gates
Indapta Therapeutics
Series AFeb 2022$50M
$50M
Co-investors: Lori Hu (Vertex Ventures HC)
Artiva Biotherapeutics
Series BFeb 2021$120M
Series AJun 2020$78M
$200M
Co-investors: Brian Daniels (5am Ventures), Yvonne Yamanaka (venBio), Bong Koh (Venrock)

Laura Stoppel's Experience

Associate RA Capital ManagementPresent
Senior Associate RA Capital ManagementPresent
Analyst RA Capital ManagementPresent
Board Member Artiva BiotherapeuticsPresent
Board Member Nimbus TherapeuticsPresent
Board Member Acumen Pharmaceuticals, Inc.Present
Principal RA Capital ManagementPresent
Board Member International Rett Syndrome FoundationPresent
Board Member CellCentricPresent
Board Member Verdiva BioPresent
Board Member Infinant HealthPresent
Partner RA Capital ManagementPresent

Laura Stoppel's Education

Harvard University BA Biology, Psychology
Massachusetts Institute of Technology Doctor of Philosophy (PhD) Neuroscience